An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
- 1 July 2013
- journal article
- research article
- Published by Elsevier BV in Cell Host & Microbe
- Vol. 14 (1), 93-103
- https://doi.org/10.1016/j.chom.2013.06.004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Highly Conserved Protective Epitopes on Influenza B VirusesScience, 2012
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A HemagglutininsScience, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D-Structural Biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D-Structural Biology, 2009
- The biology of influenza virusesVaccine, 2008
- Mortality due to Influenza in the United States—An Annualized Regression Approach Using Multiple-Cause Mortality DataAmerican Journal of Epidemiology, 2005
- Early administration of oral oseltamivir increases the benefits of influenza treatmentJournal of Antimicrobial Chemotherapy, 2002
- Human B Cell Growth and Differentiation in the Spleen of Immunodeficient MiceThe Journal of Immunology, 2001
- The Role of Antibody Concentration and Avidity in Antiviral ProtectionScience, 1997
- A severe combined immunodeficiency mutation in the mouseNature, 1983